top of page
Prevalence of Hepatitis B and Clinical Outcomes in Inflammatory Bowel Disease Patients in a Viral-En
HCH Chan, VWS Wong, GLH Wong, W Tang, JCY Wu, and SC Ng, BMC Gastroenterology. 08, 2016. 16 (1). Little is known of the prevalence of hepatitis B virus (HBV) infection and its effect on choice of therapy and disease course in patients with inflammatory bowel disease (IBD). In this retrospective cohort, hepatitis B surface antigen (HBsAg), liver function tests, and IBD disease characteristics were recorded. Logistic regression was used to identify factors associated with alter
Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Populati
SC Ng, WK Leung, HY Shi, MKK Li, CM Leung, CKM Ng, FH Lo, YT Hui, SWC Tsang, YK Chan, CK Loo, KH Chan, AJ Hui, WH Chow, M Harbord, JYL Ching, M Lee, V Chan, W Tang, IFN Hung, J Ho, WC Lao, MTL Wong, SF Sze, EHS Shan, BCY Lam, RWH Tong, LY Mak, SH Wong, JCY Wu, FKL Chan, and JJY Sung, Inflammatory Bowel Diseases. 05, 2016. 22: p. 1954-1960. [IF: 4.525] Incidence of inflammatory bowel disease (IBD) is increasing in Asia, but population-based prevalence data are limited. We exam

Publications
Selected Journal Papers
bottom of page